🇺🇸 FDA
Pipeline program

TEV-45779

TV45779-IMB-30086

Phase 3 other completed

Quick answer

TEV-45779 for Chronic Urticaria is a Phase 3 program (other) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Chronic Urticaria
Phase
Phase 3
Modality
other
Status
completed

Clinical trials